Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Aarti Pharmalabs Gets Single Observation in USFDA Inspection at Tarapur Unit

Alembic Pharma bags USFDA final approval for Pantoprazole Sodium for Injection for GERD

Written By Ruchika Sharma2 April 2025 2:48 PM IST

Vadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug Administration (USFDA)...

Abhayrab Safe via Authorised Channels, Clarifies Indian Immunologicals Amid Fake Vaccine Alerts

Emcure Pharma arm Gennova advances development of Nipah virus vaccine

Written By Ruchika Sharma1 April 2025 3:20 PM IST

Pune: Emcure Pharmaceuticals Ltd. subsidiary Gennova Biopharmaceuticals Ltd., is advancing the development of a pathbreaking...

AstraZeneca gets USFDA approval for perioperative Imfinzi for bladder cancer

Written By Ruchika Sharma1 April 2025 2:15 PM IST

Imfinzi was generally well tolerated, and no new safety signals were observed in the neoadjuvant and adjuvant settings.

Wockhardt Gets 5-Year NPPA Price Control Exemption for Nafithromycin 400 mg Tablets

Wockhardt Zaynich successfully treats paediatric cancer patient with recalcitrant blood, liver infection

Written By Ruchika Sharma1 April 2025 12:15 PM IST

The patient was treated with Zaynich for 41 days, resulting in the successful resolution of the infection.

Govt extends deadline for submitting applications under PLI Scheme

Morepen Labs receives anti-allergy API Loratadine approval for export to China

Written By Ruchika Sharma1 April 2025 11:15 AM IST

This marks a Morepen's strategic entry into one of the world's largest pharmaceutical markets.

Eli Lilly to Acquire Ajax Therapeutics in USD 2.3 Billion Cancer Drug Push

Eli Lilly Alzheimer's drug rejected by EU regulator

Written By Ruchika Sharma31 March 2025 5:20 PM IST

Indianapolis: Indianapolis-based pharmaceutical giant Eli Lilly has faced a setback as the European Union's drug regulator rejected its...

SPARC Bags USFDA Rare Pediatric Disease Priority Review Voucher for Sezaby

Sun Pharma Advanced Research Company submits IND application for SBO-154 to USFDA

Written By Ruchika Sharma31 March 2025 1:09 PM IST

Mumbai: Sun Pharma Advanced Research Company Ltd. has announced submission of an Investigational New Drug (IND) application with the US...

Bristol Myers Squibb Wins USFDA Approval for Opdivo Combo in Hodgkin Lymphoma

Bristol Myers Squibb receives positive EMA Committee opinion for Perioperative Opdivo plus Chemo in Resectable Non-Small Cell Lung Cancer plus PD-L1

Written By Ruchika Sharma30 March 2025 12:15 PM IST

Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...

Sanofi Dupixent approved in Japan for COPD

Written By Ruchika Sharma30 March 2025 10:00 AM IST

Dupixent is intended for injection under the skin (subcutaneous injection) and is given every other week.

USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers Squibb

Bristol Myers Squibb gets Positive EMA Committee opinion for subcutaneous formulation of Opdivo across Multiple Solid Tumor Indications

Written By Ruchika Sharma29 March 2025 5:47 PM IST

Princeton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...

AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia Treatment

AstraZeneca Pharma India to discontinue manufacturing, marketing of angina drug from April 1

Written By Ruchika Sharma29 March 2025 2:21 PM IST

Bangalore: AstraZeneca Pharma India Limited has announced that the Company will be discontinuing the manufacturing and marketing of the product...

Novartis to Acquire Excellergy in USD 2 Billion Deal to Boost Food Allergy Pipeline

Novartis radioligand therapy Pluvicto gets USFDA nod for expanded indication

Written By Ruchika Sharma29 March 2025 1:15 PM IST

Basel: Novartis has announced that the US Food and Drug Administration (FDA) has approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok